| |
| |
|
| Insider
Information: |
Meyer Steven J |
| Relationship: |
Director |
| City: |
Deerfield |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
206,320 |
|
|
Indirect Shares
|
159,185 |
|
|
| Direct
Value |
$6,569 |
|
|
|
Indirect Value
|
$4,270 |
|
|
| Total
Shares |
365,505 |
|
|
| Total
Value |
$10,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -97.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akorn Inc |
AKRX |
Director |
2020-03-03 |
138,154 |
2020-03-03 |
159,185 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
Director |
2019-03-04 |
68,166 |
2014-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRX |
Akorn Inc |
Director |
– • – |
2020-03-03 |
4 |
B |
$0.99 |
$14,850 |
I/I |
15,000 |
145,225 |
2.1 |
% |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2020-03-02 |
4 |
B |
$1.08 |
$91,800 |
I/I |
85,000 |
130,225 |
2.1 |
% |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2019-08-15 |
4 |
B |
$2.50 |
$25,000 |
D/D |
10,000 |
183,154 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2019-08-14 |
4 |
B |
$2.70 |
$27,000 |
D/D |
10,000 |
173,154 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2019-05-29 |
4 |
B |
$3.75 |
$37,500 |
D/D |
10,000 |
163,154 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2019-05-20 |
4 |
B |
$4.10 |
$61,500 |
D/D |
15,000 |
153,154 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
30,760 |
138,154 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,083 |
68,166 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,189 |
107,394 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
60,083 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
56,083 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2017-05-18 |
4 |
B |
$12.21 |
$97,680 |
D/D |
8,000 |
52,083 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,088 |
93,205 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-12-28 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,750 |
1,250 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-12-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,750 |
225 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-12-15 |
5 |
A |
$0.00 |
$0 |
I/I |
2,100 |
2,100 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-12-15 |
5 |
D |
$0.00 |
$0 |
I/I |
(2,100) |
16,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-11-04 |
4 |
B |
$10.75 |
$107,489 |
D/D |
10,000 |
44,083 |
2.39 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-09-01 |
4 |
OE |
$13.57 |
$6,785 |
D/D |
500 |
34,083 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-08-04 |
4 |
OE |
$13.57 |
$16,806 |
D/D |
1,194 |
33,583 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-07-06 |
4 |
OE |
$14.44 |
$10,036 |
D/D |
695 |
32,389 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,661 |
85,117 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-06-07 |
4 |
OE |
$13.57 |
$16,806 |
D/D |
1,194 |
31,694 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • – |
2016-06-02 |
4 |
OE |
$6.62 |
$165,500 |
D/D |
25,000 |
80,456 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2016-05-18 |
4 |
OE |
$13.57 |
$6,785 |
D/D |
500 |
30,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
